Maria V. Maliandi
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Phase I Trial of Intravenous VCN-01 Oncolytic Adenovirus and Durvalumab in Patients with Head and Neck Metastatic Squamous Cell Carcinoma Refractory to Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 12, 2026
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: March 01, 2022
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects.
Journal: Journal for immunotherapy of cancer
Published: September 11, 2021
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation.
Journal: Molecular therapy oncolytics
Published: December 18, 2020
Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 30, 2020
National funding for mental health research in Finland, France, Spain and the United Kingdom.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: January 19, 2017
A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel.
Journal: Oncotarget
Published: February 08, 2016
AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation.
Journal: Molecular cancer
Published: February 04, 2015
Combining oncolytic virotherapy and cytotoxic therapies to fight cancer.
Journal: Current pharmaceutical design
Published: March 14, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026